Big Pharma’s clinical trials in China are quietly bypassing global oversight, raising urgent alarms about data transparency and ethical practices. This emerging gap poses a serious risk to the trust and integrity of drug approvals worldwide
Browsing: The Wire China
Global pharmaceutical giants are turbocharging their investments in Chinese drugmakers, eager to seize the explosive growth of the country’s biotech sector and tap into its enormous market potential. This bold strategic move is transforming the industry landscape like never before
China is facing a growing rocket shortage as the demand for satellite launches and space missions skyrockets. Industry experts warn that this shortfall could stall the nation’s daring plans for space exploration